Arkolith/Insider Trading/CINC/Form 4

Sofinnova Venture Partners X, L.P.

10% OwnerCinCor Pharma, Inc. (CINC) · full profile →Form 4 · filed Jan 13, 2022
Net Buying
Open-Market Buys
$5.2M
Open-Market Sells
$0
Net Open-Market Flow
$5.2M
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 11, 2022Buy(P)325K$16.00$5.2M5.6M
Jan 11, 2022Conversion(C)5.2M——5.2M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 11, 2022Conversion(C)4.3M—$00
Jan 11, 2022Conversion(C)13.6M—$00

Transaction Codes

P
Open-market purchase
C
Conversion of a derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-22-003197) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML